LncRNA XIST Promotes Atherosclerosis by Regulating miR-599/TLR4 Axis

被引:29
作者
Yang, Kechun [1 ]
Xue, Yun [1 ]
Gao, Xiaoya [1 ]
机构
[1] Nanjing Med Univ, Dept Endocrinol, Affiliated Changzhou 2 Peoples Hosp, 68 Gehu Rd, Changzhou 213161, Peoples R China
关键词
Atherosclerosis (AS); XIST; miR-599; TLR4; CELL-PROLIFERATION; CERVICAL-CANCER; APOPTOSIS; KNOCKDOWN; PROGRESSION; INFLAMMATION; CONTRIBUTES;
D O I
10.1007/s10753-020-01391-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Long noncoding RNAs (lncRNAs) have been reported to be implicated in various biological and pathological processes. However, the function and mechanism of XIST in vascular smooth muscle cells (VSMCs) remains unknown. The levels of XIST, miR-599, and TLR4 were tested by RT-qPCR. VSMCs and human mononuclear cells (U937) treated with ox-LDL were used as atherosclerosis (AS) cell models. The CCK-8 assay was adopted to detect cell viability. Cell apoptosis was examined by the TUNEL assay. A dual-luciferase reporter assay was employed to investigate the interaction between miR-599 and XIST or TLR4. In this research, we uncovered that the XIST level was elevated in the serum of AS patients and ox-LDL-treated AS cell models. Functional analysis revealed that XIST depletion restrained cell proliferation, while induced the apoptosis in AS cell models. Besides, miR-599 was verified to be a direct downstream target of XIST and miR-599 inhibitor reversed the effects of XIST knockdown on AS progression. Finally, we demonstrated that XIST increased TLR4 expression by serving as a ceRNA of miR-599. All these findings manifested the role of the XIST/miR-599/TLR4 axis in AS development.
引用
收藏
页码:965 / 973
页数:9
相关论文
共 29 条
[1]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[2]   Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1 [J].
Chen, Xing ;
Xiong, Dongsheng ;
Ye, Liya ;
Wang, Kai ;
Huang, Lingfei ;
Mei, Shuangshuang ;
Wu, Jinhong ;
Chen, Shanshan ;
Lai, Xiaoli ;
Zheng, Lingzhi ;
Wang, Meifen .
CANCER CELL INTERNATIONAL, 2019, 19 (1)
[3]   lncRNA 430945 promotes the proliferation and migration of vascular smooth muscle cells via the ROR2/RhoA signaling pathway in atherosclerosis [J].
Cui, Chuan ;
Wang, Xing ;
Shang, Xiao-Ming ;
Li, Li ;
Ma, Yi ;
Zhao, Guo-Yu ;
Song, Yu-Xin ;
Geng, Xue-Bin ;
Zhao, Bi-Qiong ;
Tian, Mei-Rong ;
Wang, Hong-Ling .
MOLECULAR MEDICINE REPORTS, 2019, 19 (06) :4663-4672
[4]   Advanced atherosclerosis is associated with inflammation, vascular dysfunction and oxidative stress, but not hypertension [J].
Dinh, Quynh N. ;
Chrissobolis, Sophocles ;
Diep, Henry ;
Chan, Christopher T. ;
Ferens, Dorota ;
Drummond, Grant R. ;
Sobey, Christopher G. .
PHARMACOLOGICAL RESEARCH, 2017, 116 :70-76
[5]   MiR-135a represses oxidative stress and vascular inflammatory events via targeting toll-like receptor 4 in atherogenesis [J].
Du, Xian-Jin ;
Lu, Jing-Min .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (07) :6154-6161
[6]   miR-185 silencing promotes the progression of atherosclerosis via targeting stromal interaction molecule 1 [J].
Fang, Ming ;
Li, Yanfei ;
Wu, Yingbiao ;
Ning, Zhongping ;
Wang, Xuejun ;
Li, Xinming .
CELL CYCLE, 2019, 18 (6-7) :682-695
[7]   The suppression of ox-LDL-induced inflammatory response and apoptosis of HUVEC by lncRNA XIAT knockdown via regulating miR-30c-5p/PTEN axis [J].
Hu, W-N ;
Duan, Z-Y ;
Wang, Q. ;
Zhou, D-H .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (17) :7628-7638
[8]   RETRACTED: MicroRNA-599 suppresses glioma progression by targeting RAB27B (Retracted article. See vol. 22, 2021) [J].
Jiang, Yu ;
Wang, Xiaohui ;
Zhang, Ji ;
Lai, Renchun .
ONCOLOGY LETTERS, 2018, 16 (01) :1243-1252
[9]   RETRACTED: Circ_0008035 contributes to cell proliferation and inhibits apoptosis and ferroptosis in gastric cancer via miR-599/EIF4A1 axis (Retracted Article) [J].
Li, Chang ;
Tian, Yuan ;
Liang, Yun ;
Li, Qingchun .
CANCER CELL INTERNATIONAL, 2020, 20 (01)
[10]  
Li FP, 2018, EUR REV MED PHARMACO, V22, P7439, DOI 10.26355/eurrev_201811_16284